5
Views
1
CrossRef citations to date
0
Altmetric
Original Papers

Feasibility of Percutaneous Radiofrequency Ablation for Pulmonary Malignancies in the Hands of the Surgeon

, , , , , , , , , & show all
Pages 267-271 | Published online: 11 Mar 2016

References

  • Jemal A., Thomas A., Murray T. et al. Cancer statistics. Cancer J Clin, 2002, 52: 23–47.
  • Dienemann H. Principles of surgical treatment in localized non-small cell lung cancer. Lung Cancer, 2001, 33 (Suppl 1): S3–8.
  • Hoffman PC, Mauer AM, Vokes EE. Lung Cancer. Lancet 2000; 355: 479–85.
  • Pearson F. G. Current status of surgical resection for lung cancer. Chest, 1994; 106: 337S-9S.
  • Pollock R. E. Manual of clinical oncology. 7th ed. New York, NY: Wiley-Liss, 1999.
  • Licker M., Spiliopoulos A., Frey J. G. et al. Risk factors for early mortality and major complications following pneumonectomy for non-small cell lung carcinoma of the lung. Chest, 2002, 121: 1890–7.
  • Steinke K., Glenn D., King J. et al. Percutaneous imaging-guided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol, 2004, 11: 207–12.
  • Friedel G., Pastorino U., Buyse M., Ginsberg R. J., Girard P. et al. Resection of lung metastases: long-term results and prognostic analasis based on 5206 cases-the International Regestry of Lung Metastases. Zentralbl Chir, 1999, 124: 96–103.
  • Zimmermann F. B., Bamberg M., Molls M., Jeremic B. Radiation therapy alone in early stagenon-small cell lung cancer. Semin Surg Oncol, 2003,; 21: 91–7.
  • Furley S. A., Izzo F., Ellis L. M., Vauthey J. N., Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg, 2000, 232: 381–91.
  • Lencioni R., Goletti O., Armillotta N., Paolicchi A., Moretti M. et al. Radiofrequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial. Eur Radiol, 1998, 8: 1205–11.
  • Rosenthal D. I., Springfield D. S., Gebhardt M. C., Rosenberg A. E., Mankin H. J. Osteoid osteoma: percutaneous radio-frequency ablation. Radiology, 1995, 197: 451–4.
  • Hadjicostas P., Malakounides N., Varíanos C., Kitiris E., Lerni F., Symeonides P. Radiofrequency ablation in pancreatic cancer. HPB (Oxford) 2006, 8: 61–4.
  • McGovern et al. Radiofrequency ablation of renal cell carcinoma via imaged guided needle electrode. J Urol, 1999, 161: 599–600.
  • Dupuy D. E., Zagoria R. J., Akerley W., Mayo-Smith W. W., Kavanagh P. V., Safran H. Percutaneous radiofrequency ablation of malignancies in the Lung. AJR, 2000, 174: 57–9.
  • Gillams A. et al. Lung tumour ablation-where are we now ? Cancer Imaging, 2008, 8: 116–117.
  • de Baère T., Palussière J., Aupérin A. et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology, 2006, 240: 587–96.
  • Simon C. J., Dupuy D. E., DiPetrillo T. A. et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology, 2007, 243: 268–275.
  • Lencioni R., Crocetti L., Cioni R. et al. Response to radiofrequen-cy ablation of pulmonary tumours: a prospective, intention-to-treat, multicenter clinical trial (the RAPTURE study). Lancet Oncol, 2008, 9: 621–8.
  • Steinke K., Sewell P. E., Dupuy D. E. et al. Pulmonary radio-frequency ablation-An international study survey. Anticancer Research, 2004, 24: 339–344.
  • Raut C. P., Izzo F., Marra P. et al. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol, 2005, 12: 616–28.
  • Chen M. S., Li J. Q., Zheng Y. et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepate-ctomy for small hepatocellular carcinoma. Ann Surg, 2006, 243: 321–8.
  • Pennathur A., Abbas G., Gooding. W. et al. Imaged-guided radio-frequency ablation of lung neoplasm in 100 consecutive patients by a thoracic surgical service. Ann Thor Surg, 2009, 88: 1601–8.
  • Ambrogi M. C., Lucchi M., Dini P. Percutaneous radiofrequency ablation of lung tumours: result in the mid-term. EJCTS, 2006, 30: 177–83.
  • Steinke K., Glenn D., King J., Morris D. L. Percutaneous pulmonary radiofrequency ablation: difficulty achieving complete ablations in big lung lesions. BJR, 2003, 76: 742–5.
  • Higaki F., Okumura Y., Sato S. et al. Preliminary retrospective investigation of FDG-PET/CT timing in follow-up of ablated lung tumor. Ann Nucl Med, 2008, 22: 157–63.
  • Suh R. D., Wallace A. B., Sheehan R. E., Heinze S. B., Goldin J. G. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results. Radiology, 2003, 229: 821–9.
  • Herrera L. J., Fernando H. C., Perry Y., Gooding W. E., Buenaventura P., Christie N. A., Luketich J.D. Radiofrequency ablation of pulmonary malignant tumors in non surgical candidates. J Thorac Cardiovasc Surg, 2003, 125: 929–37.
  • Yasui K., Kanazawa S., SanoY. et al. Thoracic tumors treated with CT-guided radiofrequency ablation. Initial experience. Radiology, 2004, 231: 850–7.
  • Akeboshi M., Yamakado K., Nakatsuka A. et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol, 2004, 15: 463–70.
  • Lee J. M., Jin G. Y., Goldberg S. N. et al. Percutaneous radiofre-quency ablation for inoperable non-small cell lung cancer and metastasis: preliminary results. Radiology, 2004, 230: 125–34.
  • Fernando H. C., De Hoyos A., Landreneau R. J. et al. Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates. J Thorac Cardiovasc Surg, 2005, 129: 639–44.
  • Senan S., Lagerwaard F. Stereotactic radiotherapy for stage I lung cancer: current results and new developments. Cancer Radiother, 2010, 14: 115–8.
  • Haasbeek C. J., Lagerwaard F. J., Antonisse M. E., Slotman B. J., Senan S. Stage I non-small cell lung cancer in patients aged > or = 75 years: outcomes after stereotactic radiotherapy. Cancer, 2010; 116: 406–14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.